Literature DB >> 11165451

Completeness and timeliness of tuberculosis case reporting. A multistate study.

A B Curtis1, E McCray, M McKenna, I M Onorato.   

Abstract

BACKGROUND: Tuberculosis (TB) control activities are contingent on the timely identification and reporting of cases to public health authorities to ensure complete assessment and appropriate treatment of contacts and identification of secondary cases. We report the results of a multistate evaluation of completeness and timeliness of reporting of TB cases in the United States during 1993 and 1994.
METHODS: To determine completeness of TB reporting, laboratory log books, death certificates, hospital discharge, Medicaid databases, and pharmacy databases were reviewed in seven states to identify possible unreported cases. Timeliness of TB reporting was calculated using the number of days between date of TB diagnosis and date of report to the local or state health department. Cases reported >7 days after diagnosis were considered to have delayed reporting.
RESULTS: Of 2711 cases identified through review of secondary data sources, 14 (0.5%) were previously unreported to public health. The largest yield of unreported cases was identified through review of laboratory records; 13 of the 14 unreported cases were identified, of which eight were found only through this method. Timeliness of reporting varied between sites from a median of 7 days to a median of 38 days. The number of cases with delayed reporting varied from 5% to 53% between sites. Factors associated with delayed reporting included infectiousness, type of provider, diagnosing provider, and reporting source.
CONCLUSIONS: Through a review of several different secondary data sources, few unreported TB cases were detected; however, timeliness of reporting was poor among the reported cases.

Entities:  

Mesh:

Year:  2001        PMID: 11165451     DOI: 10.1016/s0749-3797(00)00284-1

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  26 in total

1.  Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB.

Authors:  Victoria M Beltran; Kathleen McDavid Harrison; H Irene Hall; Hazel D Dean
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

2.  Real-time surveillance for tuberculosis using electronic health record data from an ambulatory practice in eastern Massachusetts.

Authors:  Michael S Calderwood; Richard Platt; Xuanlin Hou; Jessica Malenfant; Gillian Haney; Benjamin Kruskal; Ross Lazarus; Michael Klompas
Journal:  Public Health Rep       Date:  2010 Nov-Dec       Impact factor: 2.792

3.  Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.

Authors:  K Owusu-Edusei; S M Marks; R Miramontes; E L Stockbridge; C A Winston
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

4.  Understanding the burden of tuberculosis among American Indians/Alaska Natives in the U.S.: a validation study.

Authors:  Laura Jean Podewils; Emily Alexy; Stephani Jean Driver; James E Cheek; Robert C Holman; Dana Haberling; Meghan Brett; Eugene McCray; John T Redd
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

5.  Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study.

Authors:  Christopher Vinnard; Carla A Winston; E Paul Wileyto; Rob Roy Macgregor; Gregory P Bisson
Journal:  BMJ       Date:  2010-09-06

6.  Assessment of a syndromic surveillance system based on morbidity data: results from the Oscour network during a heat wave.

Authors:  Loïc Josseran; Anne Fouillet; Nadège Caillère; Dominique Brun-Ney; Danièle Ilef; Gilles Brucker; Helena Medeiros; Pascal Astagneau
Journal:  PLoS One       Date:  2010-08-09       Impact factor: 3.240

7.  Factors associated with mortality in patients with tuberculosis.

Authors:  David J Horne; Rebecca Hubbard; Masahiro Narita; Alexia Exarchos; David R Park; Christopher H Goss
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

8.  Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis.

Authors:  A C Pettit; J Cummins; L A Kaltenbach; T R Sterling; J V Warkentin
Journal:  Int J Tuberc Lung Dis       Date:  2013-02-07       Impact factor: 2.373

9.  Laboratory reporting of tuberculosis test results and patient treatment initiation in California.

Authors:  Lisa Pascopella; Steffi Kellam; John Ridderhof; Daniel P Chin; Arthur Reingold; Edward Desmond; Jennifer Flood; Sarah Royce
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Black race, sex, and extrapulmonary tuberculosis risk: an observational study.

Authors:  Christina T Fiske; Marie R Griffin; Holt Erin; Jon Warkentin; Kaltenbach Lisa; Patrick G Arbogast; Timothy R Sterling
Journal:  BMC Infect Dis       Date:  2010-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.